ABSTRACT
INTRODUCTION
Immunoglobulins (glycoproteins also called antibody) are secreted by plasma cells in response to antigens exposure and consist in a major effector product of humoral immunity (TIZARD, 2002) . These immunoglobulins are also widely used in the fi eld of diagnostics and scientifi c research being employed either for detection or quantifi cation of antibodies and specifi c antigens associated with various diseases by several techniques such as immunodiffusion, ELISA, and Western blotting. Historically, the animal species chosen for antibody production to be used for diagnostic purposes have been of mammalian origin. These antibodies are obtained from blood collected either by repeated bleeding or heart puncture which may frequently result in distress or even death of the animal. The production of IgY antibodies from immunized chicken eggs is an excellent alternative to the traditional methods. This review will describe the structural and functional characteristics of avian IgY, focusing on its potential as an important tool for immunodiagnosis.
The IgY
Immunoglobulin Y (IgY) is the major antibody in birds, reptiles, and lungfi sh (WARR et al., 1995) . In birds, the IgY is found mainly in blood and in the fl uid fraction of the egg providing protection to newly hatched chick (SCHADE et al., 2005 ).
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The antibodies transfer from serum to eggs was fi rst demonstrated by KLEMPERER (1893) , however this discovery remained for a long period with no scientifi c applications. When animal welfare became more relevant in scientifi c studies, researchers began to seek alternatives to reduce the indiscriminate use of animals for research and diagnostic purposes. Although IgY and IgG are sometimes used as synonyms in the scientifi c literature, the term IgY has become universally accepted based on its unique features (LESLIE & CLEM, 1969; SCHADE et al., 1996; TIZARD, 2002) .
Structural and functional features of IgY
Like IgG, IgY contains two heavy and two light polypeptide chains, shaped in the Y characteristics and presents two binding sites for the antigen. IgY and IgG are eluted from diethylaminoethyl cellulose with low ionic strength buffers (WARR et al., 1995) . However there are striking differences that must be considered: there is little or no immunological crossreactivity between IgY and mammalian IgG. IgY has a higher molecular weight (~180kDa and ~160kDa to IgG) due to an extra constant domain in its heavy chain (H), lacks a well-defi ned hinge region and has an unique oligosaccharide in its structure. It has been proposed that the extra domain (CH2) may be the evolutionary precursor to the mammalian IgG hinge region (WARR et al., 1995) . IgY is also capable of mediate anaphylactic reactions, a function attributed to IgE in mammals (CARLANDER, 2002) . In fact, other similarities between IgY and IgE, including a similar intra chain disulphide bond in their extra heavy chain domain, lead to suggest that IgY is the ancestral molecule to both IgG and IgE, and molecular genetic studies have confi rmed these fi ndings (WARR et al., 1995) . Fc region of IgY mediates most biological effector functions, such as complement fi xation, anaphylactic reactions and opsonization, whereas the Fab region contains the antigen binding sites (DAVISON et al., 2008) . The H chain (Mw 65,105kDa) of IgY, called upsilon ("υ" capital letter H) has one variable (V) and four constant (C) regions whereas the light chain (Mw 18,660kDa) is composed of one V and one C region. The light chain is lighter than its mammalian counterpart and has restricted mobility of the hinge region (Cυ2) (CARLANDER, 2002) . IgY is stable at pH 4-9 and up to 65ºC in aqueous condition. However, high salt conditions or the addition of stabilizing reagents increase its resistance to heat, acid extreme pH and high pressure (SHIMIZU et al., 1992) .
It has been identifi ed in some anseriform birds and reptiles the truncated form of IgY, with evolutionary origins still unknown (OTA et al., 2003) . This truncated IgY have low molecular weight (~120kDa) and contain only two constant domains without two terminal domains of the heavy chain (TIZARD, 2002) . This truncated isoform of IgY is produced as a result of alternative splicing of heavy chain messenger RNA, being called IgY (∆Fc). However, LI et al. (2012) have demonstrated that IgY and IgY(∆Fc) are codifi ed in different genes in some species, like in the red-eared turtle. As the truncated isoform lacks a functional Fc region, it cannot undertake the usual immunoglobulin effector functions such as complement activation or Fc receptor binding (TIZARD, 2002) . The immunoglobulin Y, full-sized and truncated, can be found in the same individual as in some ducks and geese, or only one form, like in Gallus domesticus where only the whole IgY is present (LIU & HIGGINS, 1990; KITAGUCHI et al., 2008) .
Previous studies have shown the presence of three immunoglobulin classes in birds (IgA, IgM and IgY), but IgY is found in higher concentration (5 to 15mg/mL) than IgM (1 to 3mg/mL) and IgA (0.3 to 0.5mg/mL) in serum (ROSE et al., 1974; KOWALCZYK et al., 1985) . As for mammals, the IgM is the predominant isotype produced in the avian primary humoral response while IgY is the predominant form in the secondary response (DAVISON et al., 2008) .
Chicken IgY is predominantly systemic rather than a secretory antibody but can be also found in duodenal contents, tracheal washings and seminal plasma (LESLIE & CLEM, 1969) , besides the egg yolk. The IgY plays a similar biological role as mammalian IgG, being considered the major immunoglobulin providing defense against infectious agents. Additionally, hatched chickens acquire an effective humoral immunity against common avian pathogens when absorb IgY from the egg yolk, until the complete maturation of the immune system (SCHADE et al., 2005) .
Transport of IgY from the serum to egg yolk
There is a delay of fi ve to six days since the appearance of IgY in serum until it is found in the yolk (DAVISON et al., 2008) . The amount of IgY transferred across the follicular epithelium into the yolk is proportional to the IgY concentrations in serum (HAMAL et el., 2006) . However, the concentration of IgY in egg yolk varies greatly between different bird species and even between chicken lines (CARLANDER, 2002) . Yolk IgY concentrations were reported to be in the range of 7.9mg/ml to 20-25mg/ ml (ROSE et al., 1974; KOWALCZYK et al., 1985) , depending on the analytical method used. About 100-200mg of total IgY can be extracted from a single egg with 2-10% being antigen specifi c (SCHADE et al., 1994; CARLANDER, 2002) . IgM and IgA can reach concentrations of 0.15 and 0.7mg/ml into the white eggs, respectively (ROSE et al., 1974) . While low amounts of the IgM and IgA isotypes can be detected in the yolk, higher concentrations can be detected in the albumen (CARLANDER, 2002) .
Studies performed in chickens have demonstrated that ovarian IgY incorporation happen through a specifi c receptor-mediated endocytosis and require the Fc region of the intact immunoglobulin for its binding and transport (KITAGUCHI et al., 2008) . While both IgY and IgY(∆Fc) can be incorporated into the egg yolk, the full-length form (IgY) is preferentially incorporated (LIU & HIGGINS, 1990) . KITAGUCHI et al. (2008) speculate that IgY fragments lacking in the Fc region, Fab and F(ab´) 2 fragments, can be incorporated by fl uid-phase endocytosis without binding to the receptor or carrier protein after passing through the fi ltration gate.
IgY production
Chickens can be used for antibody production throughout their egg laying period. Different routes and various protocols have been reported so far but it is often diffi cult to compare the different methods described. For practical and economic reasons, chickens kept under fi eld conditions are usually vaccinated intramuscularly in the breast muscle but subcutaneous immunization has also been used (SCHADE et al., 1996; CARLANDER et al., 2002) . Injection of the antigen by intramuscular route frequently results in higher antibody levels by day 28 th after immunization (WOOLEY & LANDON, 1995) . Chickens immunized by the intramuscular route continue producing specifi c antibodies during more than 200 days or can be used for the entire laying period depending basically on the antibody titres induced (HORTON et al., 1984; SCHADE et al., 1996) .
The total number of immunization required will depend upon the type and dose of the antigen, as well as on the particular adjuvant employed. Whether the antibody titres begin to decrease, booster immunizations can be applied during the laying period. A primary vaccination and a booster should be given preferentially before the laying period, with an interval of 6 weeks for emulsion-type adjuvants and 4 weeks for lipopeptide adjuvants (SCHADE et al., 1996) . According to SCHADE et al. (1996) , conventional housing should be used for scientifi c purpose, when antibodies are used for therapeutic and human purposes the use of specifi c pathogens free chickens is compulsory. It is also possible to increase yolk antibody production by using a high producing chicken line and by genetic selection within the same line (CARLANDER, 2002) .
Chicken IgY exhibits high avidity (10 9 L/ mol) even after the fi rst immunization. In order to reach similar avidity values (10 10 L/mol), a sheep, for example, must receive four boosters (WOOLEY & LANDON, 1995) . LARSSON et al. (1998) , studied the immune response in chickens using small amounts of mammalian antigens, and observed a good immune response obtained with the use of 0.1-1.0μg of bovine serum albumin. It was suggested that various concentrations of the antigen should be combined with the adjuvant. However, 25-100μg of antigen per immunization are usually used, although it is possible to obtain a good immune response with only 1μg per immunization (CARLANDER, 2002) .
Isolation and purifi cation of IgY
Currently, there are several methods of isolation and purifi cation of functionally active chicken IgY from egg yolk described, even for largescale purifi cation. Nevertheless, purity and yield vary greatly from method to method and require intense optimization for each experiment (CARLANDER, 2002) . The choice of a specifi c method depends on the yield and purity desired, fi nal application of the IgY as well as material cost, technology, labor skills and scale of extraction.
Formerly, widespread adoption of the use of IgY-based protocols have suffered from limitations due to existing IgY purifi cation protocols, especially those concerning the high lipid content of egg yolk which is known to interfere with affi nitybased purifi cation steps (HANSEN et al., 1998) . For this, all IgY purifi cation methods require an initial delipidation step to extract insoluble lipids and lipoproteins (KO & UHN, 2007; TAN et al., 2012) and then a subsequent step of separation. Among the currently accepted commercial and laboratory delipidation techniques, the most commonly used, involve either the use of water dilution under acidic conditions (AKITA & NAKAI, 1993 ), chloroform-PEG (POLSON, 1990 , polyanionic polysaccharides such as xanthan (HATTA & KIM, 1990) , dextran sulphate or other natural gums such as pectin (JENSENIUS et al., 1981; CHANG et al., 2000) , solvents such as acetone, detergents such as SDS Ciência Rural, v.44, n.1, jan, 2014.
(SRIRAM & YGEESWARAN, 1999), carrageenan (HATTA & KIM, 1990) , aqueous 2-phase system with phosphate and triton X-100 (STALBERG & LARSSON, 2001) or simple freeze and slow thaw cycling (SVENDSEN et al., 1995) . These various IgY crude extraction methods give different results considering recovery and purity of levels obtained.
After the extraction step, three types of separation can be applied to eliminate the contaminants: precipitation with ammonium sulfate (KO & UHN, 2007) , or sodium sulfate (WOOLEY & LANDON, 1995) , or caprylic acid-ammonium sulfate (McLAREN et al., 1994) , chromatography (HANSEN, 1998) and fi ltration (HERNÁNDEZ-CAMPOS et al. 2010 ). Several of these techniques could be included in one total clean-up procedure. Among these methods, AKITA & NAKAI (1993) suggested the water dilution method under acidic conditions as the most effi cient and economical procedure for large-scale production of IgY from egg yolk when compared with polyethylene glycol and dextran sulphate methods in terms of yield, purity and activity of IgY.
Ultrafi ltration is one of the best methods of reduce the volume of egg yolk extract, and the effi cacy of this methodology is greatly infl uenced by the presence of lipids or lipoproteins in the solution (KO & UHN, 2007) . Therefore, complete removal of lipids or lipoproteins from extract of egg yolk is required. Changes of pH value in egg yolk solution infl uence the extent of interactions between polysaccharides and proteins, the precipitation of polysaccharide-lipoprotein complexes, and the recovery of immunoactivity (SAMANT et al., 1993) . CHANG et al. (2000) reported that addition of 0.1% of λ-carrageenan was effective in removing lipoproteins from the water extract of egg yolk at pH 5. TAN et al. (2012) , have demonstrated an alternative methodology to isolate IgY from chicken egg yolks by using a mix of κ-carrageenan, pectin and CaCl2 as delipidation agent with use of ammonium sulphate ((NH 4 ) 2 SO 4 ) as an IgY precipitation reagent. This method also allowed the isolation of immunologically active IgY which can be used for further downstream immunotechnological processes.
Purity level of IgY from the ammonium sulfate method is higher than the cation exchange chromatography. The chromatography could handle only a small amount of samples, unlike the ammonium sulfate precipitation. Besides, the ammonium sulfate precipitation would be more effi cient and useful purifi cation method than cation exchange chromatography for the large-scale preparation of IgY (KO & UHN, 2007) . After IgY precipitation by NaCl, column chromatography (JENSENIUS et al., 1981) is frequently used in the fi nal purifi cation step. However, chromatography columns are generally expensive and impractical for the large-scale production of antibodies (KO & UHN, 2007) .
IgY in immunodiagnostic
Immunoglobulin Y has distinctive properties which can be exploited in various fi elds of research, diagnostics and therapy. Since the 1970's, studies were performed in order to elucidate the functional and morphological characteristics of the poorly known immunoglobulin Y. Thereafter, there was an increase in the availability of research regarding IgY reagents (purifi cation kits, standards, and labelled antibodies specifi cally against IgY), and studies related with IgY production enabling the expansion of applications in immunodiagnostic techniques. In 1995, the production came to be called "IgY Technology" (WARR et al., 1995) , which is the internationally accepted term for describing the production and use of this antibody. Furthermore, the "European Centre for the Validation of Alternative Methods" (ECVAM) strongly recommends that yolk antibodies should be used as an alternative to mammalian antibodies for the animal welfare (SCHADE et al., 1996) .
The IgY can be harvested from the egg yolk instead of serum, thus making blood sampling obsolete. The antibody productivity of an egg-laying hen is greater than a similar sized mammal (HAU & HENDRIKSEN, 2005) and the IgY concentration in the serum of adult hens can reach approximately 5-7mg/ml. As a laying hen produces approximately 20 eggs per month, over 2 grams of IgY can be isolated during this period corresponding approximately the IgY content of 300ml of serum or 600ml of blood. Only larger mammals can produce equal amounts of serum antibodies. Chicken antibodies, therefore, constitute a much less expensive vehicle for use in diagnostic purposes (CARLANDER, 2002) .
The use of IgY can also be advantageous in immunological tests where the interference caused by IgG antibodies can be problematic, particularly, the sensitivity of the assay increases. One example is the rheumatoid factor (RF) that reacts with IgG from different mammalian species and also with mouse monoclonal antibodies (CARLANDER, 2002) . RF is usually found in serum samples from patients with rheumatoid arthritis, but can also be found in patients with other diseases and even in 3-5% of healthy individuals. Interference by anti-IgG antibodies and antibody-binding substances have been demonstrated in approximately 40% of serum samples from healthy individuals in an immunoradiometric assay (CARLANDER, 2002) . Another fact is the increasing number of patients treated in vivo with mouse monoclonal antibodies. This treatment often evokes an antibody response in the patient resulting in production of human anti-mouse IgG antibodies (HAMA). HAMA may also be found in serum from patients who have not been treated with antibodies. The problem of RF and HAMA interference will increase as the sensitivity of the assay increases. Chicken IgY does not react with RF or HAMA and can be used to avoid interference due to these factors (LARSSON et al., 1992) .
Chicken antibodies can also be used to reduce interference caused by mammalian complement activation in immunological assays. The complement cascade can be triggered after adding a fresh and undiluted serum sample to an assay, with subsequent binding of complement components to mammalian antibodies blocking the antigen-binding sites (LARSSON et al., 1992) . The controls and standards used for immunological assays generally contain inactivated complement, whereas the complement activity in patient samples might differ, not only among patients but also between samples from the same patient. This difference in activity between the standards and the clinical samples might cause an analytical error (LARSSON et al., 1992; CARLANDER, 2002) .
Whenever there is a risk of false positive results due to reactions between Fc region of mammalian antibodies and staphylococcal protein A or streptococcal protein G, chicken antibodies could be a tool to circumvent these problems. Unlike IgG, IgY antibodies do not bind to bacterial Fc receptors, such as staphylococcal protein A or streptococcal protein G (JENSENIUS et al., 1981) . However, one disadvantage is that neither protein A nor protein G can be used for the purifi cation of chicken IgY (SCHADE et al., 1996) .
Another important advantage arises from the phylogenetic distance and genetic background that distinguishes birds from mammals improving the likelihood that an immune response will be elicited against antigens or epitopes that may be nonimmunogenic in mammals (SPILLNER et al., 2012) . Due to the evolutionary distance between chicken and mammalian immunoglobulins, IgY recognizes more epitopes when the immunogen used is a mammalian protein highly conserved. This feature can result in amplifi cation of the signal, emphasizing the advantages of using IgY over IgG as the fi rst antibody in some types of immunological reactions (CARLANDER, 2002) . It is a well-known concept that a stronger immune response is elicited when the distance between the antigen source and the immune system increases. It has also been shown that chicken antibodies have 3-5 times more affi nity to antibodies of pigs than the rabbit IgG for signal amplifi cation in immunological test (HORTON et al., 1984; OLOVSSON & LARSSON, 1993) .
The limited fl exibility of the avian IgY may account for the inability to precipitate antigens at physiological salt concentrations (WARR et al., 1995) . IgY and IgY(∆Fc) both possess two antigenbinding sites and should, in principle, precipitate or agglutinate multivalent antigens but this does not always occur. Most chicken antibodies bind antigen strongly but display precipitating properties only at raised salt concentrations. Duck antibodies generally fail to exhibit effi cient precipitation or agglutination reactions (HIGGINS et al., 1988) . The nonprecipitating duck antibodies do not acquire the ability to precipitate antigen at raised salt concentrations (WARR et al., 1995) .
More recently, chicken antibodies libraries have attracted scientifi c interest with increased reports on the isolation of chicken-derived antibody fragments. Such interest might, at least partially, be attributed to the genetic diversifi cation which is achieved differently in chickens compared with the complexity of the mammalian mechanisms. In other words, avian species utilize a unique mode of DNA recombination, named gene conversion, resulting in a large and diverse antibody repertoire upon antigen priming (SPILLNER et al., 2012) . This could be exemplifi ed by the development of a humanized chicken monoclonal anti-IL12 antibody (NISHIBORI et al., 2006) . It is also important to keep in mind that recombinant technologies currently available can generate monoclonal IgY or IgY-like antibodies from combinatorial libraries, sometimes without animal immunization (SPILLNER et al., 2012) .
Taking together, all these characteristics clearly show substantial advantages of IgY technology in many medical areas, especially for diagnosis. Specifi c chicken antibodies have been successfully raised against a wide variety of antigens including proteins, peptides, lipid hormones and carbohydrate components from viruses, bacteria, fungi, plants and animals (SCHADE et al., 1994) . Several studies have also shown promising results in the development of techniques for immunodiagnostic using IgY, such as immunoassays tests to detect circulating antigen Ciência Rural, v.44, n.1, jan, 2014.
of Schistosoma japonicum (CAI et al., 2012) , development of IgY antibodies against proteins of Pythium insidiosum (RANGEL et al., 2010) , use in antigen capture-ELISA (JULIARENA et al. 2007; VEERASAMI et al., 2008) , among others.
CONCLUSION
IgY antibodies have many advantages over IgG antibodies such as strong avidity, scalable productivity, low assay background, and applicability to many immunoassays providing a strategy for improvement of assay performance and accuracy. Other advantageous features of IgY include a broader antigen-binding host range, absence of activation of the mammalian complement cascade and interaction with rheumatoid factors, or bacterial and human Fc receptors, certainly helping to reduce the costs of clinical and research immunological tests. Finally, the use of IgY represents an alternative method to utilization of mammal IgG and it is in agreement with international efforts, which aim to reduce or even replace animals in scientifi c experimentation not to mention other desirable characteristics and applications for immunodiagnostic.
